These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 501802)

  • 21. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.
    Engelstad M; Smith GL
    Virology; 1993 Jun; 194(2):627-37. PubMed ID: 8503178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The polypeptide composition of vaccinia-infected cell membranes and rifampicin bodies.
    Payne LG; Kristensson K
    Virus Res; 1990 Aug; 17(1):15-30. PubMed ID: 2220070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The formation and function of extracellular enveloped vaccinia virus.
    Smith GL; Vanderplasschen A; Law M
    J Gen Virol; 2002 Dec; 83(Pt 12):2915-2931. PubMed ID: 12466468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of haemagglutinin in the envelope of extracellular vaccinia virus particles.
    Payne LG; Norrby E
    J Gen Virol; 1976 Jul; 32(1):63-72. PubMed ID: 986420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus.
    McIntosh AA; Smith GL
    J Virol; 1996 Jan; 70(1):272-81. PubMed ID: 8523536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccinia virus core protein VP8 is required for virus infectivity, but not for core protein processing or for INV and EEV formation.
    Wilcock D; Smith GL
    Virology; 1994 Jul; 202(1):294-304. PubMed ID: 8009841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The exit of vaccinia virus from infected cells.
    Smith GL; Law M
    Virus Res; 2004 Dec; 106(2):189-97. PubMed ID: 15567497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An investigation of incorporation of cellular antigens into vaccinia virus particles.
    Krauss O; Hollinshead R; Hollinshead M; Smith GL
    J Gen Virol; 2002 Oct; 83(Pt 10):2347-2359. PubMed ID: 12237415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation.
    Mathew E; Sanderson CM; Hollinshead M; Smith GL
    J Virol; 1998 Mar; 72(3):2429-38. PubMed ID: 9499104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus.
    Parkinson JE; Smith GL
    Virology; 1994 Oct; 204(1):376-90. PubMed ID: 8091668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The existence of an envelope on extracellular cowpox virus and its antigenic relationship to the vaccinia envelope.
    Payne LG
    Arch Virol; 1986; 90(1-2):125-33. PubMed ID: 3729722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replacing the SCR domains of vaccinia virus protein B5R with EGFP causes a reduction in plaque size and actin tail formation but enveloped virions are still transported to the cell surface.
    Rodger G; Smith GL
    J Gen Virol; 2002 Feb; 83(Pt 2):323-332. PubMed ID: 11807225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular and extracellular vaccinia virions enter cells by different mechanisms.
    Vanderplasschen A; Hollinshead M; Smith GL
    J Gen Virol; 1998 Apr; 79 ( Pt 4)():877-87. PubMed ID: 9568984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional analysis of vaccinia virus B5R protein: role of the cytoplasmic tail.
    Lorenzo MM; Herrera E; Blasco R; Isaacs SN
    Virology; 1998 Dec; 252(2):450-7. PubMed ID: 9878625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complementation of P37 (F13L gene) knock-out in vaccinia virus by a cell line expressing the gene constitutively.
    Borrego B; Lorenzo MM; Blasco R
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():425-432. PubMed ID: 10073703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein B5 is required on extracellular enveloped vaccinia virus for repulsion of superinfecting virions.
    Doceul V; Hollinshead M; Breiman A; Laval K; Smith GL
    J Gen Virol; 2012 Sep; 93(Pt 9):1876-1886. PubMed ID: 22622330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel virus binding assay using confocal microscopy: demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors.
    Vanderplasschen A; Smith GL
    J Virol; 1997 May; 71(5):4032-41. PubMed ID: 9094681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus.
    Roper RL; Wolffe EJ; Weisberg A; Moss B
    J Virol; 1998 May; 72(5):4192-204. PubMed ID: 9557708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion.
    Sanderson CM; Frischknecht F; Way M; Hollinshead M; Smith GL
    J Gen Virol; 1998 Jun; 79 ( Pt 6)():1415-25. PubMed ID: 9634084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane.
    Roberts KL; Breiman A; Carter GC; Ewles HA; Hollinshead M; Law M; Smith GL
    J Gen Virol; 2009 Jul; 90(Pt 7):1582-1591. PubMed ID: 19264647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.